The M2 macrophage-derived exosome miR-155 eliminates transduction inhibition of IGF1R by targeting HuR (Human antigen R), after which activating the PI3K–AKT pathway and promoting the development of ccRCC [81]. The gene discussed is ELAVL1; the disease is nonpapillary renal cell carcinoma.